MYC expression + MYC rearrangement
|
Lymphoma
|
MYC expression + MYC rearrangement
|
Lymphoma
|
Aurora kinase inhibitor Sensitive: C3 – Early Trials
|
Aurora kinase inhibitor Sensitive: C3 – Early Trials
|
MYC expression + MYC rearrangement
|
Lymphoma
|
MYC expression + MYC rearrangement
|
Lymphoma
|
BET inhibitor Sensitive: C3 – Early Trials
|
BET inhibitor Sensitive: C3 – Early Trials
|